Bethesda, Maryland Wednesday, July 2, 2025, 18:00 Hrs [IST] ...

Lupin receives US FDA approval for loteprednol etabonate ophthalmic gel: Our Bureau, Mumbai Wednesday, July 2, 2025, 11:40 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...

Parexel to strengthen regulatory, medical and AI expertise; appoints Lola Fashoyin-Aje and Tala Fakhouri to its consulting team: Our Bureau, Bengaluru Wednesday, July 2, 2025, 16: ...

Repronovo announces first participant included in US phase 2 trial of RPN-001 to treat MALE INFERTILITY: Lausanne, Switzerland Wednesday, July 2, 2025, 14:00 Hrs [IST] ReproNovo, ...

Moderna reports positive results from phase 3 efficacy study of P304 for seasonal influenza vaccine: Cambridge, Massachusetts Wednesday, July 2, 2025, 16:00 Hrs [IST] Moderna, Inc ...

NIH study shows breast cancer risk in younger women may be influenced by hormone therapy: Bethesda, Maryland Wednesday, July 2, 2025, 13:00 Hrs [IST] Scientists at the National In ...

Nymi and Caliber Technologies ink pact to enable passwordless authentication in pharma manufacturing: Our Bureau, Bengaluru Wednesday, July 2, 2025, 15:30 Hrs [IST] Nymi, an Innom ...

US FDA clears Iksuda Therapeutics’ IND application for IKS014: New Castle, England Wednesday, July 2, 2025, 15:00 Hrs [IST] Iksuda Therapeutics, a clinical stage and UK-based bi ...

AstraZeneca Pharma India gets CDSCO approval for treating endometrial cancer in the country: Our Bureau, Bengaluru Wednesday, July 2, 2025, 15:15 Hrs [IST] AstraZeneca Pharma Indi ...

SLAs agree for compliance of norms regarding approval of new drugs: Gireesh Babu, New Delhi Wednesday, July 2, 2025, 08:00 Hrs [IST] The drug control authorities in the states and ...

University of Salford, CSIR-IGIB and ORDI host glaucoma awareness and advocacy workshop: Our Bureau, Bengaluru Wednesday, July 2, 2025, 17:15 Hrs [IST] The University of Salford ( ...

Our Bureau, Bengaluru Wednesday, July 2, 2025, 16:15 Hrs [IST] Merck is back with its fourth edition of the Merck Young Scientist ...